Mark Daniels - Concepedia

Author

Mark Daniels

Also Known As

Favela-Prezas R., Leslie, Michelle E., M DANIELS, M. Daniels, M. J. Daniels, MARK DANIELS, Mark Daniels, Mark Harmel, Mark J Daniels, Mark J. Daniels

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Jaeb Center for Health Research Joslin Diabetes Center Children's Hospital of Orange County University of Virginia Scripps Research Institute

About

Mark Daniels is an author at Jaeb Center for Health Research specializing in medicine, diabetes, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.2K
2	Engineering	3	3	380
3	Health Sciences	3	3	167
4	Natural Sciences	1	1	297
5	Public Health	1	1	177

Mark Daniels

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
The Plasma Membrane of Arabidopsis thaliana Contains a Mercury-Insensitive Aquaporin That Is a Homolog of the Tonoplast Water Channel Protein TIP Mark Daniels, T. Erik Mirkov, Maarten J. Chrispeels PLANT PHYSIOLOGY Molecular BiologyCytoskeletonCellular PhysiologyHomology Gamma-tipMip Homolog	1994	297
Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device A. M. James Shapiro, David Thompson, Thomas Donner, Cell Reports Medicine Tissue EngineeringEngineeringImmunologyPancreas TransplantationBiomedical Engineering	2021	284
Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States Stephanie N. DuBose, Julia M. Hermann, William V. Tamborlane, The Journal of Pediatrics ObesityMetabolic SyndromeType 1Childhood ObesityHealth Policy	2015	177
The EVERSHED receptor-like kinase modulates floral organ shedding in<i>Arabidopsis</i> Michelle E. Leslie, Michael W. Lewis, Ji‐Young Youn, Development BiologyPlant Molecular BiologySignal TransductionEvershed Receptor-like KinaseGenetics	2010	123
CAST AWAY, a Membrane-Associated Receptor-Like Kinase, Inhibits Organ Abscission in Arabidopsis Christian A. Burr, Michelle E. Leslie, Sara Orlowski, PLANT PHYSIOLOGY	2011	103
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial Lori M. Laffel, Thomas Danne, Georgeanna J. Klingensmith, The Lancet Diabetes & Endocrinology Metabolic SyndromeDiabetes ManagementYoung PeopleCardiovascular DiseaseInsulin Management	2023	98
Long-Acting C-Peptide and Neuropathy in Type 1 Diabetes: A 12-Month Clinical Trial John Wahren, Howard L. Foyt, Mark Daniels, Diabetes Care	2016	85
The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange Kara Mizokami‐Stout, Zoey Li, Nicole C. Foster, Diabetes Care	2020	84
Encapsulated stem cell–derived β cells exert glucose control in patients with type 1 diabetes Bart Keymeulen, Kaat De Groot, Daniel Jacobs‐Tulleneers‐Thevissen, Nature Biotechnology	2023	83
Factors Associated With Microalbuminuria in 7,549 Children and Adolescents With Type 1 Diabetes in the T1D Exchange Clinic Registry Mark Daniels, Stephanie N. DuBose, David M. Maahs, Diabetes Care	2013	77

Page 1